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LETTERS TO THE EDITOR
Atypical manifestations of simple  Mendelian  patterns  of  inheritance,  while  a few  oth-
4,5e
i
t
d
p
s
s
b
v
s
e
2
p
a
c
p
t
i
s
(
H
d
(
I
A
c
s
f
t
TEpstein-Barr virus: red alert for
primary immunodeﬁciencies
Manifestac¸ões atípicas do vírus
de  Epstein-Barr: alerta vermelho
para  imunodeﬁciências primárias
Dear  Editor,
The  Jornal  de  Pediatria  has  published  an  elegant  review
paper  entitled  ‘‘Atypical  manifestations  of  Epstein-Barr
virus  in  children:  a  diagnostic  challenge’’.1 The  authors
performed  a  literature  review  including  the  last  30  years
of  publications  on  atypical  manifestations  associated  with
an  Epstein-Barr  virus  (EBV)  infection.  However,  I  would
like  to  complement  their  review  by  providing  a  partic-
ularly  important  point  of  view  related  to  atypical  EBV
infections.
EBV  is  a  gamma-1  herpes  virus  restricted  to  primate
hosts,  characterized  by  its  persistence  in  the  B-lymphoid
system,  and  its  capacity  to  stimulate  B-cells  growth  by
coordinating  the  expression  of  latent  cycle  genes.2 Most  EBV-
infected  individuals  are  asymptomatic  or  present  infectious
mononucleosis  syndrome  with  a  benign  course,  especially
teenagers  and  young  adults.2,3 In  its  normal  course,  EBV
infects  B-cells  and  the  immune  system  controls  the  virus
using  a  complex  mechanism  that  involves  NK,  iNKT,  CD4,
and  CD8  cells.  Genetic  alterations  leading  to  functional  NK
or  T-cell  impairment  may  lead  to  a  failure  in  the  EBV  control
mechanisms.3
Primary  immunodeﬁciencies  (PIDs)  are  a  group  of  dif-
ferent  diseases  that  cause  alterations  in  the  development
and/or  function  of  the  immune  system,  leading  to  an
increased  susceptibility  to  infections  and,  in  some  cases,
increased  incidence  of  autoimmune  diseases  and  malig-
nancies.  Most  PID  cases  are  genetic  diseases  that  follow
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n  the  genetic  approaches  in  the  last  years  has  increased
he  pace  at  which  causative  genes  for  PIDs  are  being
iscovered.5
Recently,  Palendira  and  Rickson,  in  a  educational  and  sim-
le  method,  divided  PID  patients  into  groups  to  explain  the
usceptibility  to  EBV  infections:  (1)  PIDs  that  are  selectively
usceptible  to  EBV;  (2)  PIDs  with  broader  virus  susceptibility,
ut  frequent  EBV  disease;  (3)  PIDs  generally  susceptible  to
iral  and  nonviral  infections;  and  (4)  PIDs  with  an  inherent
usceptibility  to  lymphoma.2
Group  1  includes  the  X-linked  lymphoproliferative  dis-
ases  type  1,  caused  by  SH2D1A  gene  mutations,  and  type
,  associated  with  XIAP  gene  mutations.  In  both  diseases,
atients  could  present  severe  infectious  mononucleosis;
nd  acute  disease  could  result  in  a  cytokine  storm  that
auses  macrophage  activation  and  hemophagocytic  lym-
hohistiocytosis  (HLH).2,4 In  another  review,  authors  added
hree  different  PIDs  to  this  group,  including  mutations
n  the  genes  PRF1  (perforin  deﬁciency,  autosomal  reces-
ive  (AR)),  STXBP2  (munc18-2  deﬁciency,  AR),  and  UNC13D
munc13-4  deﬁciency,  AR),  which  are  also  associated  with
LH  and  the  development  of  chronic  and  severe  EBV
isease.6
Group  2  contains  PIDs  caused  by  mutations  in  genes  CD27
CD27  deﬁciency,  AR),  MAGT1  (XMEN  syndrome,  X-linked),
TK  (ITK  deﬁciency,  AR),  CORO1A  (coronin-1A  deﬁciency,
R),  FCGR3  (CD16  deﬁciency,  AR),  and  MCM4  (MCM4  deﬁ-
iency,  AR).2 The  diseases  in  this  group  showed  an  increased
usceptibility  not  only  to  EBV,  but  also  to  other  herpes  virus
amily  and,  in  some  cases,  to  HPV.4
Group  3  has  complex  PIDs  with  different  predisposi-
ions  to  several  microorganisms,  including  EBV  infections.
he  PIDs  included  in  this  group  are  result  of  mutations  in
enes  PIK3CD  (Activated  PI3-kinase  delta  syndrome,  auto-
omal  dominant  (AD)),  STK4  (MST1  deﬁciency,  AR),  ZAP70
Zap-70  deﬁciency,  AR),  CTPS1  (CTPS1  deﬁciency,  AR),
ARD11  (CARD11  deﬁciency,  AR),  LRBA  (LRBA  deﬁciency,
R),  GATA2  (mono  MAC  syndrome  or  GATA2  deﬁciency,  AD),
YST  (Chediak-Higashi  syndrome,  AR),  and  hypomorphic
utations  in  ARTEMIS  and  DNA  ligase  IV,  both  associated  with
menn  syndrome.2,4,6
The  PIDs  in  group  4  present  different  degrees  of  immune
ystem  deﬁciency,  which  are  also  associated  with  increased
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ancer  incidence  and  the  involvement  of  EBV  in  some  of
hese  tumors,  especially  lymphomas.  This  group  includes
IDs  with  mutations  in  genes  WAS  (Wiskott--Aldrich  syn-
rome,  X-linked),  ATM  (Ataxia  telangiectasia  syndrome,  AR),
nd  TNFRSF6  (ALPS-FAS,  AD  and  AR).2,4,6
The  message  for  all  pediatricians  is  to  consider  EBV  as  a
ausative  agent  in  clinical  pictures  similar  to  those  described
y  Bolis  et  al.  In  addition  to  the  immune  system  impairment
ssociated  with  treatment  for  several  diseases,  we  must  also
onsider  these  situations  as  a  red  alert  for  primary  immuno-
eﬁciencies  in  pediatric  patients.  Recognizing  PIDs  may  be
ssential  to  achieve  a  better  management  for  patients  with
typical  EBV  infections.
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ear  Editor,
uman  primary  immunodeﬁciency  disease  (PID)  is  a  condi-
ion  where  mutations  in  single  immune  system  genes
redispose  individuals  to  certain  infectious  agents.  The
uman  herpesviruses  are  a  challenge  of  immune  compe-
ence,  since  most  of  these  agents  are  widespread  in  the
opulation;  they  are  often  acquired  silently  or  with  mild
ymptoms  in  childhood  and  then  carried  for  life  as  asymp-
and  as  a  persistent  condition.1 For  individuals  who  are
immunocompromised,  due  to  a  genetic  immunodeﬁciency  or
immunosuppressive  drug  therapy,  viral  infections  may  result
in  severe  complications  and  even  life-threatening  disease.2
PID  is  considered  a  rare  disease,  with  an  overall  inci-
dence  of  4.6  cases  of  PIDs  per  100,000  person-years  in  the
last  35  years.3 However,  neither  the  true  incidence  nor  the
true  prevalence  of  PID  are  known.  Although  there  have
been  estimates  of  these  parameters  from  geographically
limited  studies,  those  estimates  were  based  only  on  diag-
nosed  cases.  Therefore,  PID  may  be  far  more  common  than
previously  estimated.  Surveys  suggest  prevalence  rates  for
diagnosed  PID  as  1:2000  for  children,  1:1200  for  all  persons,
and  1:600  households.4
Speciﬁc  gene  mutations  in  PID  patients  are  responsible
for  susceptibility  to  Epstein--Barr  virus  (EBV)  infections,  as
highlighted  in  the  letter  to  the  editor  of  the  Jornal  de  Pedia-
tria  entitled  ‘‘Atypical  manifestations  of  Epstein--Barr  virus:
red  alert  for  primary  immunodeﬁciencies’’.  Although  PIDomatic  latent  infections.  PID  patients  are  therefore  likely
o  be  exposed  to  these  viruses  relatively  early  in  life  and
ill  have  to  deal  with  them  both  as  a  primary  infection
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ommon,  pediatricians  should  indeed  correlate  these  two
onditions  as  mentioned  in  the  previous  letter,  since  EBV
nfects  more  than  95%  of  the  adult  population  worldwide.5
ID  incidence  has  increased  in  the  last  decades,3 and
atients  with  immunodeﬁciency  are  the  group  most
xposed  to  atypical  complications  of  EBV  among  healthy
eople.
The  strongest  predictor  of  PID  is  family  history.  Moreover,
hen  an  immunodeﬁciency  disease  is  suspected,  initial  labo-
atory  screening  should  include  a  complete  blood  count  with
